Лакутамаб

Rec. INN (наименование, зарегистрированное ВОЗ)

DB15322

2187368-16-5

immunoglobulin G1-kappa, anti-[Homo sapiens KIR3DL2 (killer cell immunoglobulin-like receptor, three Ig domains, long cytoplasmic tail 2)], monoclonal antibody;
gamma1 heavy chain (1-448) [VH (Homo sapiens IGHV7-4-1*02 (84.7%) -(IGHD) -IGHJ6*01 (92.9%)) [8.8.11] (1-118) -Homo sapiens IGHG1*03 (G1v7) (CH1 R120 (215) (119-216), hinge (217-231), CH2 S3>D (240), I117>E (333) (232-341), CH3 E12 (357), M14 (359) (342-446), CHS (447-448)) (119-448)], (221-214')-disulfide with kappa light chain (1'-214') [VKAPPA (Mus musculus IGKV6-25*01 (87.4%) - IGKJ1*01 (91.7%)/Homo sapiens IGKV1-NL1*01 (77.9%) -IGKJ4*01 (100%)) [6.3.6] (1'-107') -Homo sapiens IGKC*01 (100%) A45.1 (153), V101 (191) (108'-214')]; dimer (227-227":230-230")-bisdisulfide

Поделиться этой страницей